Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lead compound production metabolism

The reason for the lack of lead compounds from synthetic libraries in some therapeutic areas such as anti-infectives, immunosuppression, oncology, and metabolic diseases may be due to the different chemical space occupied by natural products and synthetic compounds. [Pg.10]

Toluene tends to enter brain tissue, which it affects, and accumulates in adipose tissue. Unlike benzene, toluene possesses an aliphatic side chain that can be oxidized enzymatically, leading to products that are readily excreted from the body. The metabolism of toluene is thought to proceed via oxidation of the methyl group and formation of the conjugate compound hippuric acid, as shown in Figure 13.9. [Pg.301]

While the wine contains several g/L of L-malic acid before MLR, it usually only contains between 200 mg/L and 300 mg/L of citric acid. Although the citric acid is only present in low concentrations, it is of considerable importance. On the one hand, its metabolic pathway leads to production of acetic acid, in other words, it increases the volatile acidity of the wine. However, the most important enological significance associated with fermentation of citrate is the production of diacetyl and other acetonic compounds, which affect the wine aroma. [Pg.39]

M. E. Schroeder Another related area where basic research may have an impact on product discovery is in the support of optimization once lead compounds are identified. In this case the in vitro assay can tell the chemist if the modifications that he is making are increasing or decreasing the activity at the target site. I think most chemists would like to know whether changes in insecticidal activity of a series of compounds are due to changes in penetration or metabolism or due to changes in the inherent activity. [Pg.324]

Decomposition of TAL in soil is also likely to be rapid in either sterile or non-sterile soils (half-life less than 1 day for TEL)." The products were partially alkylated lead compounds, which in turn decay or are metabolized by organisms. [Pg.630]

As described previously, virtual screening and in silico design will accelerate the discovery of active lead compounds with new chemical scaffolds. The in silico prediction of physicochemical and ADME (absorption distribution metabolism elimination) properties, however, also are very critical for lead development. Actually, pharmacokinetics and toxicity have been identified as important causes of costly late-stage failures in drug development. The recently developed in silico approaches will increase model productivity in fine-tuned lead optimization to improve compound design and lead optimization. [Pg.126]

For example, van Heek and coworkers observed a lead candidate that underwent extensive first-pass metabolism and yet elicited a significant level of pharmacological activity (van Heek et al., 1997). To evaluate the biological activity of the in vivo biotransformation products, they collected samples of bile from rats dosed with a lead compound and directly administered the samples to a bile duct cannulated rats via an intraduodenal cannula. As a control study, the parent compound prepared in a blank bile was dosed in a similar fashion to the recipient rats. The results indicated that the in vivo activity elicited by the bile samples was higher than the parent control sample, clearly indicating the presence of an active metabolite(s) that was more potent than the parent compound. To identify the active component, the bile sample was then fractionated and each fraction tested for biological activity. The structure of the metabolite was then established following the detection of the active fraction. As mentioned before, further modification of the active metabolite led to the discovery of ezetimibe. [Pg.252]

For example. Van Heek and co-workers observed a lead candidate that underwent extensive first-pass metabolism and yet elicited a significant level of pharmacological activity (Van Heek et al., 1997). To evaluate the biological activity of the in vivo biotransformation products, they collected samples of bile from rats dosed with a lead compound and directly administered the samples to bile duct cannulated rats via an intraduodenal cannula. As a control... [Pg.245]


See other pages where Lead compound production metabolism is mentioned: [Pg.407]    [Pg.228]    [Pg.385]    [Pg.338]    [Pg.250]    [Pg.408]    [Pg.14]    [Pg.277]    [Pg.83]    [Pg.259]    [Pg.14]    [Pg.54]    [Pg.160]    [Pg.3]    [Pg.281]    [Pg.57]    [Pg.259]    [Pg.233]    [Pg.56]    [Pg.104]    [Pg.272]    [Pg.9]    [Pg.273]    [Pg.2195]    [Pg.666]    [Pg.320]    [Pg.560]    [Pg.365]    [Pg.512]    [Pg.513]    [Pg.64]    [Pg.449]    [Pg.746]    [Pg.539]    [Pg.33]    [Pg.290]    [Pg.114]    [Pg.2]    [Pg.270]    [Pg.350]    [Pg.609]    [Pg.590]    [Pg.1365]   
See also in sourсe #XX -- [ Pg.519 , Pg.520 , Pg.520 , Pg.521 ]




SEARCH



Lead compound production

Lead compounds

Lead production

Lead products

Metabolic products

Metabolism products

© 2024 chempedia.info